Therefore, the identification of large MKs with hyperlobulated nuclei in BM of CML patients should prompt additional genetic testing including CALR mutations to exclude the coexistence of a Ph-negative MPN. This evidence concerns the gene CALR and myeloproliferative neoplasm.